[1] [2] Increasing levels of CD38, a membrane-bound NADase that destroys both NAD+ and its precursor nicotinamide mononucleotide, are thought to be the cause of the age-related decline in NAD+ levels, according to a 2016 study in mice, which exhibit age-related declines in NAD+ levels similar to those seen in humans
CJC-1295 is a growth hormone-releasing hormone (GHRH) analog
Choose NAD+ IV Therapy if you want to: Choose Glutathione IV Therapy if you want to: Combine Both for a comprehensive, full-body wellness protocol that enhances energy, recovery, detoxification, and longevity
GHRP-6 plus Mod GRF 1-29 (CJC-1295 without DAC) This is the most common and well-validated GHRP-6 stack
Learn More Comprehensive longevity protocol combining tissue regeneration, telomere activation, and mitochondrial energy optimization for whole-body anti-aging